Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Vorinostat in Treating Patients With Metastatic Melanoma of the Eye

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by National Cancer Institute (NCI)
Sponsor:
Collaborators:
Institut Curie Paris
Memorial Sloan Kettering Cancer Center
Moffitt Cancer Center P2C
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01587352
First received: April 26, 2012
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)